Tier 3 — preclinical

Induction of autophagy by spermidine promotes longevity

Tobias Eisenberg, Heide Knauer, Alexandra Schauer, Sabrina Büttner, Christoph Ruckenstuhl, Didac Carmona-Gutierrez, Julia Ring, Sabrina Schroeder, Christoph Magnes, Lucia Antonacci, Heike Fussi, Luiza Deszcz, Regina Hartl, Elisabeth Schraml, Alfredo Criollo, Evgenia Megalou, Daniela Weiskopf, Peter Laun, Gino Heeren, Michael Breitenbach, Beatrix Grubeck-Loebenstein, Eva Herker, Birthe Fahrenkrog, Kai-Uwe Fröhlich, Frank Sinner, Nektarios Tavernarakis, Nadege Minois, Guido Kroemer, Frank Madeo
Nature Cell Biology 2009 11(11):1305-1314

Bibliography

PubMed
PMID 19801973

Study snapshot

DesignMulti-species experimental mechanistic study
ModelYeast, Drosophila, C. elegans, mice and human immune cells
SampleMultiple experimental cohorts across yeast, flies, nematodes, mice and human immune cells
InterventionExperimental spermidine administration or polyamine manipulation
DurationModel-specific acute, aging and lifespan experiments; varies by model
EndpointsLifespan; Autophagy; Histone acetylation; Oxidative stress; Necrosis; Autophagy-related transcription

What the study showed, in plain terms

This is the foundational spermidine-autophagy longevity paper. Spermidine extended lifespan in yeast, flies and worms, reduced oxidative damage in aging mice and induced autophagy across multiple systems including human cells.

Key findings

Autophagy was required for much of the longevity effect in model organisms. The paper established a mechanism, not evidence that spermidine extends human lifespan.

What this study can and cannot tell us

Human work was cellular, not a clinical intervention. Lifespan extension occurred in model organisms and cannot be extrapolated directly to people.

Editorial review

Reviewed by the Biohack Blueprint research team

Khaled Mahmoud